X0306 4 2020-10-06 0 0001791091 Healthcare Merger Corp. HCCO 0001453072 Alyeska Investment Group, L.P. 77 WEST WACKER DRIVE, 7TH FLOOR CHICAGO IL 60601 0 0 1 0 0001456506 Alyeska Master Fund, L.P. 77 WEST WACKER DRIVE, 7TH FLOOR CHICAGO IL 60601 0 0 1 0 0001775953 Alyeska Master Fund 3, L.P. 77 WEST WACKER DRIVE, 7TH FLOOR CHICAGO IL 60601 0 0 1 0 0001822287 ALYESKA FUND GP, LLC 77 WEST WACKER DRIVE, 7TH FLOOR CHICAGO IL 60601 0 0 1 0 0001822509 ALYESKA FUND 3 GP, LLC 77 WEST WACKER DRIVE, 7TH FLOOR CHICAGO IL 60601 0 0 1 0 0001822286 ALYESKA INVESTMENT GROUP, LLC 77 WEST WACKER DRIVE, 7TH FLOOR CHICAGO IL 60601 0 0 1 0 0001822281 ALYESKA INVESTMENTS, LLC 77 WEST WACKER DRIVE, 7TH FLOOR CHICAGO IL 60601 0 0 1 0 0001822280 PAREKH ANAND 77 WEST WACKER DRIVE, 7TH FLOOR CHICAGO IL 60601 0 0 1 0 Class A Common Stock 2020-10-06 4 P 0 98381 10.04 A 2768555 D Class A Common Stock 2020-10-06 4 P 0 97599 10.04 A 2746579 D Class A Common Stock 2020-10-06 4 P 0 782 10.04 A 21976 D Class A Common Stock 2020-10-06 4 P 0 97599 10.04 A 2746579 I Footnotes Class A Common Stock 2020-10-06 4 P 0 782 10.04 A 21976 I Footnotes Class A Common Stock 2020-10-06 4 P 0 98381 10.04 A 2768555 I Footnotes Class A Common Stock 2020-10-06 4 P 0 98381 10.04 A 2768555 I Footnotes Class A Common Stock 2020-10-06 4 P 0 98381 10.04 A 2768555 I Footnotes Class A Common Stock 2020-10-06 4 P 0 169603 10.05 A 2938158 D Class A Common Stock 2020-10-06 4 P 0 168258 10.05 A 2914837 D Class A Common Stock 2020-10-06 4 P 0 1345 10.05 A 23321 D Class A Common Stock 2020-10-06 4 P 0 168258 10.05 A 2914837 I Footnotes Class A Common Stock 2020-10-06 4 P 0 1345 10.05 A 23321 I Footnotes Class A Common Stock 2020-10-06 4 P 0 169603 10.05 A 2938158 I Footnotes Class A Common Stock 2020-10-06 4 P 0 169603 10.05 A 2938158 I Footnotes Class A Common Stock 2020-10-06 4 P 0 169603 10.05 A 2938158 I Footnotes Class A Common Stock 2020-10-06 4 P 0 61842 10.06 A 3000000 D Class A Common Stock 2020-10-06 4 P 0 61351 10.06 A 2976188 D Class A Common Stock 2020-10-06 4 P 0 491 10.06 A 23812 D Class A Common Stock 2020-10-06 4 P 0 61351 10.06 A 2976188 I Footnotes Class A Common Stock 2020-10-06 4 P 0 491 10.06 A 23812 I Footnotes Class A Common Stock 2020-10-06 4 P 0 61842 10.06 A 3000000 I Footnotes Class A Common Stock 2020-10-06 4 P 0 61842 10.06 A 3000000 I Footnotes Class A Common Stock 2020-10-06 4 P 0 61842 10.06 A 3000000 I Footnotes Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares. (i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds. The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest. On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively. The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act. Alyeska Investment Group, L.P., By: /s/ Jason Bragg, Chief Financial Officer 2020-10-13 Alyeska Master Fund, L.P., By: Alyeska Fund GP, LLC, By: /s/ Jason Bragg, Chief Financial Officer 2020-10-13 Alyeska Master Fund 3, L.P., By: Alyeska Fund 3 GP, LLC, By: /s/ Jason Bragg, Chief Financial Officer 2020-10-13 Alyeska Fund GP, LLC, By: /s/ Jason Bragg, Chief Financial Officer 2020-10-13 Alyeska Fund 3 GP, LLC, By: /s/ Jason Bragg, Chief Financial Officer 2020-10-13 Alyeska Investment Group, LLC, By: /s/ Jason Bragg, Chief Financial Officer 2020-10-13 Alyeska Investments, LLC, By: /s/ Anand Parekh, Managing Member 2020-10-13 /s/ Anand Parekh 2020-10-13